Ashland (ASH) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Ashland

NYSE•Basic Materials•Specialty Chemicals

$70.48+0.21(<0.01%)Pre-market

Market Cap

$3,242.08

P/E

0.0x

P/S

0.0x

P/B

0.0x

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.

How this company scores

AverageMetricSide Score: 59/100

Strongest: Cash & Earnings Quality (17/25); weakest: Growth (13/25).

Profitability15/25

Growth13/25

Balance Sheet & Red Flags14/25

Cash & Earnings Quality17/25

Strengths

Rising free cash flowRising earningsProfit converts from growthImproving margins

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 0.0x5y range 0.0x – 31.7x

Currently below its 14-quarter median.

P/S · 0.0x5y range 0.0x – 2.5x

Currently below its 20-quarter median.

P/B · 0.0x5y range 0.0x – 1.9x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

FCF consistently trails net income (avg 0.2x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume

Market Cap $3,242.08

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.84B
Q. Revenue: $497.00M
TTM EBITDA: $328.00M
TTM Op. Income: $137.00M
Q. Op. Income: $43.00M
TTM Net Income: $51.00M
Q. Net Income: $16.00M
EPS: $0.35
Shares Out.: $46

$1.84B in TTM revenue declined 1.4% YoY, reaching $497.00M last quarter. TTM EBITDA of $328.00M and TTM operating income of $137.00M show growth is flowing through to the bottom line. TTM net income of $51.00M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 2 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 34.2%
EBITDA Margin: 18.3%
Op. Margin: 8.7%
Net Margin: 3.2%

Op. margin of 8.7% is up 161.6% YoY — cost efficiency is improving. Net margin at 3.2% and gross margin of 34.2% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 0.0x
P/S Ratio: 0.0x
P/B Ratio: 0.0x

At 0.0x P/E, the stock trades below typical market levels. P/S of 0.0x and P/B of 0.0x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is up 0% — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $4.58B
Cash: $440.00M
Long-Term Debt: $1.37B
Book Value: $1.87B
D/E Ratio: 0.7
Debt/EBITDA: 15.1

With $4.58B in assets and $1.37B in long-term debt, D/E is 0.7and book value is $1.87B — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has fallen for 2 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $120.00M
TTM Free Cash Flow: $250.00M
FCF Margin: 13.6%
FCF / Net Income: 4.9

TTM FCF of $250.00M on $120.00M in operating cash flow. The FCF / Net Income ratio of 4.9x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 3 consecutive quarters — an improving trend.